Human colon cancer cells with the K-Ras mutation exhibited hyperproliferation due to hyperactivation of the MEK/ERK pathway, while N-Ras mutation conferred apoptotic resistance to colon cancer cells [200]. This evidence concerns the gene KRAS and malignant colon neoplasm.